Bergen Brunswig Corp.: The Orange pharmaceutical distributor...

Bergen Brunswig Corp.: The Orange pharmaceutical distributor earned $16.9 million, or 42 cents a share, for its fiscal 1995 third quarter, a gain of 13% from $15 million, or 39 cents a share, a year earlier. Revenue for the quarter ended June 30 reached a record $2.2 billion, a 16% increase from $1.9 billion in the company’s fiscal 1994 third period. For the first nine months, Bergin Brunswig’s profit increased 21% to $48.3 million, or $1.22 a share, from $39.9 million, or $1.03 a share, for the first three quarters of the prior year. The fiscal 1994 period included an earthquake-related charge of $775,000. Nine-month revenue advanced 11% to $6.2 billion from $5.6 billion. Robert E. Martini, chairman and chief executive, said the recently acquired Biddle & Crowther Co. was consolidated into the company’s Durr Medical medical-surgical supply division, and earlier this month, a definitive agreement was announced to acquire Colonial Healthcare Supply Co., a $180-million medical-surgical supply distributor. In addition, operations began in June at Bergen Brunswig’s New England Regional Distribution Center, located outside Boston.